Metabolic dysfunction-related liver disease as a risk factor for cancer

Alasdair Taylor, Moneeza K Siddiqui, Philip Ambery, Javier Armisen, Benjamin G Challis, Carolina Haefliger, Ewan R Pearson, Alex S F Doney, John F Dillon, Colin N A Palmer

10.1136/bmjgast-2021-000817

March 25, 2022

Ustekinumab is effective for perianal fistulising Crohn’s disease: a real-world experience and systematic review with meta-analysis

Gala M Godoy Brewer, George Salem, Muhammad A Afzal, Berkeley N Limketkai, Zadid Haq, Maryam Tajamal, Joanna Melia, Mark Lazarev, Florin M Selaru, Alyssa M. Parian

10.1136/bmjgast-2021-000702

December 17, 2021

Trends in indirect liver function marker testing in Wales from 2000 to 2017 and their association with age and sex: an observational study

Trevor Alexander Hill, Colin John Crooks, Joe West, Joanne R Morling

10.1136/bmjgast-2022-000885

April 29, 2022

A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis

Kathy Weisel, Nicola Scott, Scott Berger, Susanne Wang, Kurt Brown, Marcy Powell, Matthijs Broer, Clarissa Watts, Debra J Tompson, Susan W Burriss, Simon Hawkins, Kathy Abbott-Banner, Paul Peter Tak

10.1136/bmjgast-2021-000680

August 13, 2021

Normal alkaline phosphatase levels are dependent on race/ethnicity: National Health and Nutrition Examination Survey data

Humberto C Gonzalez, Zaid Imam, Robert Wong, Jia Li, Mei Lu, Sheri Trudeau, Stuart C Gordon, Mohammad Imam, Robert G Gish

10.1136/bmjgast-2020-000502

October 14, 2020

Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis

Edouard Louis, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, Jae Hee Cheon, Axel U Dignass, Fernando Magro, Juan Ricardo Márquez, Alexander R Moschen, Neeraj Narula, Grazyna Rydzewska, Matthew J Freddi, Simon PL Travis

10.1136/bmjgast-2021-000853

February 14, 2022